Silo Pharma (SILO) Net Cash Flow (2010 - 2026)
Silo Pharma (SILO) posted Net Cash Flow of -$846186.0 for Q1 2026, down 201.82% sequentially from $831073.0 in Q4 2025, and down 10.05% YoY from -$940716.6 in Q1 2025.
Silo Pharma (SILO) Net Cash Flow (2010 - 2026) Analysis & Trends
Silo Pharma has reported Net Cash Flow for 14 years, with the latest figure at -$846186.0 in Q1 2026.
- Quarterly Net Cash Flow fell 10.05% year-over-year to -$846186.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 383.46% YoY) and the FY2025 annual result came in at $842901.0, up 120.95% from the prior year.
- Net Cash Flow eased to -$846186.0 in Q1 2026 per SILO's latest filing, from $831073.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $3.3 million in Q4 2023 and troughed at -$6.7 million in Q1 2023.
- A 5-year average of -$755202.0 and a median of -$769165.0 in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Net Cash Flow plunged 1212.59% in 2023, then jumped 764.71% in 2024.
- Over 5 years, Net Cash Flow stood at -$885989.0 in 2022, then soared by 475.23% to $3.3 million in 2023, then plunged by 128.73% to -$955091.0 in 2024, then soared by 187.02% to $831073.0 in 2025, then slumped by 201.82% to -$846186.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$846186.0, $831073.0, and -$416045.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 225.59 Mn |
| 10 | Silo Pharma | 2.96 Mn | 2.96 Mn | - | -598,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -598,422.00 |
| Jun 30, 2026 | -598,422.00 |
| Mar 31, 2026 | -846,186.00 |
| Mar 31, 2026 | -846,186.00 |
| Dec 31, 2025 | 831,073.00 |
| Dec 31, 2025 | 831,073.00 |
| Sep 30, 2025 | -416,045.00 |
| Sep 30, 2025 | -416,045.00 |
| Jun 30, 2025 | -897,166.00 |
| Jun 30, 2025 | -897,166.00 |
| Mar 31, 2025 | -768,919.00 |
| Mar 31, 2025 | -768,919.00 |
| Dec 31, 2024 | -955,091.00 |
| Dec 31, 2024 | -955,091.00 |
| Sep 30, 2024 | 354,590.00 |
| Sep 30, 2024 | 354,590.00 |
| Jun 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | -856,035.00 |
| Mar 31, 2024 | -856,035.00 |